Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page R5
Preliminary Considerations Regarding Federal Investments in Vaccine Purchase and Immunization Services: Interim Report on Immunization Finance Policies and Practices Contents SUMMARY 1 INTRODUCTION 2 THE CARRYOVER ISSUE IN SECTION 317 EXPENDITURES 5 THE IMPACT OF THE STATE CHILDREN'S HEALTH INSURANCE PROGRAM 7 NEXT STEPS 9 REFERENCES 11 NOTES 12 APPENDIXES 14 Table 1 Annual Awards and Expenditures of Section 317 Direct Assistance (DA Vaccine Purchase Funds (in millions), 15 Table 2 Annual Awards and Expenditures of Section 317 Financial Assistance (FA) Immunization Program Funds (in millions), 16 Figure 1 Amount of New Funding Awarded as Section 317 Direct Assistance (DA) and Financial Assistance (FA), 1990–1999, 17 Figure 2 Amount of Total Annual Awards of Section 317 Funds, Direct Assistance (DA) and Financial Assistance (FA), 1990–1999, 17 Figure 3 Section 317 Grant Allocations from CDC to State and Local Immunization Programs, 1988–1999, 18 COMMITTEE BIOGRAPHIES 19